nivolumab,brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,vinblastine sulfate
seagen,bms,amgen
['brentuximab', 'hodgkin', 'lymphoma', 'nivolumab', 'nivo', 'lymsm', 'vedo', 's1826', ' vedo']
 headline results of swog s1826 showing that nivolumab-avd has better pfs than brentuximab vedotin-avd in the upfront treatment of hodgkin lymphoma, with less toxicity, a #asco23 #lymsm 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem